Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ingram Micro Holding Corp | INGM | Jan 13, 2025 | 19.95 | 0.00 |
Ingredion | INGR | Jan 13, 2025 | 131.82 | +0.77 |
Inhibikase Therapeutics | IKT | Jan 13, 2025 | 2.66 | -9.83 |
Inhibrx Biosciences | INBX | Jan 13, 2025 | 13.64 | -4.01 |
INLIF | INLF | Jan 13, 2025 | 4.95 | 0.00 |
InMed Pharmaceuticals | INM | Jan 13, 2025 | 4.22 | -2.09 |
InMode | INMD | Jan 13, 2025 | 15.97 | +0.44 |
INmune Bio | INMB | Jan 13, 2025 | 6.54 | +19.13 |
Innate Pharma ADR | IPHA | Jan 13, 2025 | 1.82 | +2.82 |
Inno Holdings | INHD | Jan 13, 2025 | 5.15 | +2.39 |
Innodata | INOD | Jan 13, 2025 | 33.43 | -7.04 |
Innospec | IOSP | Jan 13, 2025 | 107.92 | +2.58 |
InnovAge | INNV | Jan 13, 2025 | 3.62 | 0.00 |
Innovate | VATE | Jan 13, 2025 | 4.74 | -5.01 |
Innovation Beverage Group | IBG | Jan 13, 2025 | 0.89 | -7.28 |
Innovative Eyewear | LUCY | Jan 13, 2025 | 5.58 | -0.71 |
Innovative Industrial Properties | IIPR | Jan 13, 2025 | 65.03 | +2.52 |
Innovative Industrial Properties A Pref | IIPR-A | Jan 13, 2025 | 25.11 | +0.44 |
Innovative Solutions and Support | ISSC | Jan 13, 2025 | 8.49 | +0.47 |
Innovex International | INVX | Jan 13, 2025 | 15.75 | +1.74 |
Innovid | CTV | Jan 13, 2025 | 3.02 | -1.31 |
Innoviva | INVA | Jan 13, 2025 | 17.56 | +1.62 |
Innoviz Technologies | INVZ | Jan 13, 2025 | 1.61 | -8.00 |
InnSuites Hospitality | IHT | Jan 13, 2025 | 2.50 | -3.65 |
Innventure | INV | Jan 13, 2025 | 11.44 | -1.12 |
Inogen | INGN | Jan 13, 2025 | 10.33 | +8.17 |
Inotiv | NOTV | Jan 13, 2025 | 4.22 | -3.43 |
Inovio Pharmaceuticals | INO | Jan 13, 2025 | 1.90 | -4.04 |
Inozyme Pharma | INZY | Jan 13, 2025 | 1.72 | -13.78 |
InPoint Commercial Real Estate Pref A | ICR-A | Jan 13, 2025 | 18.61 | -1.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.